|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.320 USD | +0.87% |
|
+0.87% | +28.89% |
| 13/05 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| 13/05 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Quotes 5-day view: Protalix BioTherapeutics, Inc.
Delayed Quote NYSE
| 26/06/2026 | 29/06/2026 | 30/06/2026 | 01/07/2026 | 02/07/2026 | |
|---|---|---|---|---|---|
| Last | $2.300 | $2.350 | $2.330 | $2.300 | $2.320 |
| Volume | 25,44,165 | 5,40,557 | 5,00,098 | 4,36,234 | 4,72,793 |
| Change | - | +2.17% | -0.85% | -1.29% | +0.87% |
| Opening | $2.220 | $2.310 | $2.360 | $2.310 | $2.300 |
| High | $2.350 | $2.380 | $2.360 | $2.335 | $2.355 |
| Low | $2.215 | $2.255 | $2.310 | $2.260 | $2.270 |
Performance
| 1 day | +0.87% | ||
| 1 week | +0.87% | ||
| Current month | -0.43% | ||
| 1 month | +16.58% | ||
| 3 months | +7.91% | ||
| 6 months | +29.61% | ||
| Current year | +28.89% | ||
| 1 year | +50.65% | ||
| 3 years | +28.89% | ||
| 5 years | +28.89% | ||
| 10 years | -63.74% |
Volumes
marketsDaily volume
4,72,793
Estimated daily volume
4,72,793
Avg. Volume 20 sessions
7,69,377
Daily volume ratio
0.61
Avg. Volume 20 sessions USD
17,84,954.64
Record volume 1
19,12,89,000
Record volume 2
1,94,14,390
Record volume 3
1,27,16,823
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
18,69,26,209
Net sales (USD)
5,27,44,000
Number of employees
226
Sales / Employee (USD)
2,33,381
Free-Float
96.12 %
Free-Float capitalization (USD)
17,96,77,592
Average Daily Capital Traded
0.95%
Indicators
Moving average 5 days
2.32
Moving average 20 days
2.122
Moving average 50 days
2.082
Moving average 100 days
2.329
Price spread / (MMA5)
0.00%
Price spread / (MMA20)
-8.53%
Price spread / (MMA50)
-10.25%
Price spread / (MMA100)
+0.38%
STIM
RSI 9 days
65.37
RSI 14 days
62.54
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.87% | +0.87% | +50.65% | +28.89% | 19Cr | |
| +1.86% | +0.48% | +55.50% | +160.66% | 1,08200Cr | |
| +3.57% | +3.29% | +68.60% | +61.56% | 63TCr | |
| +3.99% | +3.05% | +37.93% | +89.70% | 46TCr | |
| -1.28% | +1.37% | +31.00% | +23.05% | 34TCr | |
| -1.50% | -0.63% | +39.05% | +37.57% | 30TCr | |
| -0.41% | +0.82% | +30.36% | +45.14% | 29TCr | |
| -0.89% | +2.68% | -26.71% | -40.24% | 22TCr | |
| +3.55% | +4.41% | +25.45% | +65.64% | 20TCr | |
| +4.21% | +2.65% | +17.47% | +69.95% | 16TCr | |
| Average | -0.58% | +4.46% | +32.93% | +54.19% | 36.93TCr | |
| Weighted average by Cap. | -0.81% | +5.43% | +41.73% | +81.84% |
Historical Quotes: Protalix BioTherapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
5de6a21c131f682bfeef83e51ccd.W76XxgvXdufWLzR0ev42JqV2ZhwAdAXR00r2qywbrWo.D9yh_lyINa_ufVgyE64FFJQCCFR6JEjn5wKu0k9T_ygz6vSxOLkcuO53YQ
| Date | Price | Volume | Total |
|---|---|---|---|
| 01:30:00 am | 2.320 | 21,617 | 3,77,377 |
| 01:29:58 am | 2.315 | 206 | 3,55,760 |
| 01:29:55 am | 2.320 | 100 | 3,55,554 |
| 01:29:55 am | 2.315 | 114 | 3,55,454 |
| 01:29:55 am | 2.315 | 120 | 3,55,340 |
| 01:29:55 am | 2.315 | 184 | 3,55,220 |
| 01:29:53 am | 2.315 | 130 | 3,55,036 |
| 01:29:53 am | 2.315 | 300 | 3,54,906 |
| 01:29:50 am | 2.320 | 100 | 3,54,606 |
| 01:29:50 am | 2.320 | 600 | 3,54,506 |
Course Extremes
| 1 week | 2.26 |  | 2.36 |
| 1 month | 1.94 | | 2.38 |
| Current year | 1.72 | | 3.19 |
| 1 year | 1.36 | | 3.19 |
| 3 years | 0.82 | | 3.19 |
| 5 years | 0.7 | | 3.55 |
| 10 years | 0.7 | | 15.15 |
Monthly variations
Annual variations
| 2026 | +28.89% | ||
| 2025 | -4.26% | ||
| 2024 | +5.62% | ||
| 2023 | +29.93% | ||
| 2022 | +64.72% | ||
| 2021 | -77.09% | ||
| 2020 | +10.67% | ||
| 2019 | +5.47% | ||
| 2018 | -52.96% | ||
| 2017 | +48.58% | ||
| 2016 | -56.37% | ||
| 2015 | -44.57% | ||
| 2014 | -52.70% | ||
| 2013 | -25.05% | ||
| 2012 | +5.27% | ||
| 2011 | -50.60% | ||
| 2010 | +50.76% | ||
| 2009 | +259.78% | ||
| 2008 | -45.88% | ||
| 2007 | -87.48% |
- Stock Market
- Stocks
- PLX Stock
- Quotes Protalix BioTherapeutics, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
